Article ISI
JOURNAL OF CLINICAL ONCOLOGY  (2015)

Post-hoc analyses of overall survival (OS) and progression-free survival (PFS) in the TRIO-013/LOGiC trial of lapatinib (L) in combination with capecitabine plus oxaliplatin (CapeOx)

Bang, Yung-Jue; Chung, Hyun-Choel; Jeziorski, Krzysztof; Shparyk, Yaroslav; Hoff, Paulo M.; Sobrero, Alberto F.; Protsenko, Svetlana; Buyse, Marc E.; Afenjar, Karen; Houe, Vincent; Garcia, Agathe; Huang, Yingjie; Armour, Alison; Slamon, Dennis J.; Hecht, J. Randolph